Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magneticresonance studies to identify a malignant pheochromocytoma

Citation
A. Fujita et al., Use of fusion images of I-131 metaiodobenzylguanidine, SPECT, and magneticresonance studies to identify a malignant pheochromocytoma, CLIN NUCL M, 25(6), 2000, pp. 440-442
Citations number
9
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
CLINICAL NUCLEAR MEDICINE
ISSN journal
03639762 → ACNP
Volume
25
Issue
6
Year of publication
2000
Pages
440 - 442
Database
ISI
SICI code
0363-9762(200006)25:6<440:UOFIOI>2.0.ZU;2-I
Abstract
Pheochromocytoma is a chromaffin tumor in which 10% are extra-adrenal and 1 0% are malignant, I-131 metaiodobenzylguanidine (MIBG) scintigraphy has an important role in the identification of these tumors and investigation of m etastatic lesions. The authors describe a 36-year-old woman who underwent r esection of a malignant left adrenal pheochromocytoma who was thought to ha ve metastases in the liver and para-aortic lymph nodes. Fusion images of I- 131 MIBG SPECT and magnetic resonance studies were obtained to properly ide ntify the metastatic lesions. These fusion images helped greatly in subsequ ent surgery.